DuoDote
These highlights do not include all the information needed to use DUODOTE safely and effectively. See full prescribing information for DUODOTE. DUODOTE (atropine and pralidoxime chloride injection), for intramuscular useInitial U.S. Approval: 2006
Approved
Approval ID
241f42a0-1a33-40e8-8221-201767d999e5
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Apr 4, 2022
Manufacturers
FDA
Meridian Medical Technologies® LLC
DUNS: 049504624
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
atropine and pralidoxime chloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code11704-620
Application NumberNDA021983
Product Classification
M
Marketing Category
C73594
G
Generic Name
atropine and pralidoxime chloride
Product Specifications
Route of AdministrationINTRAMUSCULAR
Effective DateOctober 12, 2017
FDA Product Classification